|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Zhang S, Zeng H, Zuo T,
Xia C, Yang Z and He J: Cancer incidence and mortality in China in
2013: An analysis based on urbanization level. Chin J Cancer Res.
29:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang C, Leighl NB, Wu YL and Zhong WZ:
Emerging therapies for non-small cell lung cancer. J Hematol Oncol.
12:452019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wu SG and Shih JY: Management of acquired
resistance to EGFR TKI-targeted therapy in advanced non-small cell
lung cancer. Mol Cancer. 17:382018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Solomon BJ, Besse B, Bauer TM, Felip E,
Soo RA, Camidge DR, Chiari R, Bearz A, Lin CC, Gadgeel SM, et al:
Lorlatinib in patients with ALK-positive non-small-cell lung
cancer: Results from a global phase 2 study. Lancet Oncol.
19:1654–1667. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhu Y, Chen CY, Li J, Cheng JX, Jang M and
Kim KH: In vitro exploration of ACAT contributions to lipid droplet
formation during adipogenesis. J Lipid Res. 59:820–829. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Allott EH, Masko EM, Freedland AR, Macias
E, Pelton K, Solomon KR, Mostaghel EA, Thomas GV, Pizzo SV, Freeman
MR, et al: Serum cholesterol levels and tumor growth in a PTEN-null
transgenic mouse model of prostate cancer. Prostate Cancer
Prostatic Dis. 21:196–203. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li J, Gu D, Lee SS, Song B, Bandyopadhyay
S, Chen S, Konieczny SF, Ratliff TL, Liu X, Xie J, et al:
Abrogating cholesterol esterification suppresses growth and
metastasis of pancreatic cancer. Oncogene. 35:6378–6388. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bandyopadhyay S, Li J, Traer E, Tyner JW,
Zhou A, Oh ST and Cheng JX: Cholesterol esterification inhibition
and imatinib treatment synergistically inhibit growth of BCR-ABL
mutation-independent resistant chronic myelogenous leukemia. PLoS
One. 12:e01795582017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohmoto T, Nishitsuji K, Yoshitani N,
Mizuguchi M, Yanagisawa Y, Saito H and Sakashita N: K604, a
specific acyl-CoA:cholesterol acyltransferase 1 inhibitor,
suppresses proliferation of U251-MG glioblastoma cells. Mol Med
Rep. 12:6037–6042. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
de Gonzalo-Calvo D, López-Vilaró L,
Nasarre L, Perez-Olabarria M, Vázquez T, Escuin D, Badimon L,
Barnadas A, Lerma E and Llorente-Cortés V: Intratumor cholesteryl
ester accumulation is associated with human breast cancer
proliferation and aggressive potential: A molecular and
clinicopathological study. BMC Cancer. 15:4602015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Kim SB, Luitel K and Shay JW:
Cholesterol depletion by TASIN-1 induces apoptotic cell death
through the ER stress/ROS/JNK signaling in colon cancer cells. Mol
Cancer Ther. 17:943–951. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao H, Wu M, Zhu L, Tian Y, Wu M, Li Y,
Deng L, Jiang W, Shen W, Wang Z, et al: Cell-penetrating
peptide-modified targeted drug-loaded phase-transformation lipid
nanoparticles combined with low-intensity focused ultrasound for
precision theranostics against hepatocellular carcinoma.
Theranostics. 8:1892–1910. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hu Y, Rao SS, Wang ZX, Cao J, Tan YJ, Luo
J, Li HM, Zhang WS, Chen CY and Xie H: Exosomes from human
umbilical cord blood accelerate cutaneous wound healing through
miR-21-3p-mediated promotion of angiogenesis and fibroblast
function. Theranostics. 8:169–184. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stephenson W: Deficiencies in the National
Institute of Health's guidelines for the care and protection of
laboratory animals. J Med Philos. 18:375–388. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zanoni P, Khetarpal SA, Larach DB,
Hancock-Cerutti WF, Millar JS, Cuchel M, DerOhannessian S, Kontush
A, Surendran P, Saleheen D, et al: Rare variant in scavenger
receptor BI raises HDL cholesterol and increases risk of coronary
heart disease. Science. 351:1166–1171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chang TY, Yamauchi Y, Hasan MT and Chang
C: Cellular cholesterol homeostasis in Alzheimer's disease. J Lipid
Res. 58:2239–2254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhao Z, Wu F, Ding S, Sun L, Liu Z, Ding K
and Lu J: Label-free quantitative proteomic analysis reveals
potential biomarkers and pathways in renal cell carcinoma. Tumour
Biol. 36:939–951. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SS, Li J, Tai JN, Ratliff TL, Park K
and Cheng JX: Avasimibe encapsulated in human serum albumin blocks
cholesterol esterification for selective cancer treatment. ACS
Nano. 9:2420–2432. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Antalis CJ, Uchida A, Buhman KK and
Siddiqui RA: Migration of MDA-MB-231 breast cancer cells depends on
the availability of exogenous lipids and cholesterol
esterification. Clin Exp Metastasis. 28:733–741. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bemlih S, Poirier MD and Andaloussi AE:
Acyl-coenzyme A: cholesterol acyltransferase inhibitor Avasimibe
affect survival and proliferation of glioma tumor cell lines.
Cancer Biol Ther. 9:1025–1032. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Qu X, Tian J, Zhang JT and Cheng JX:
Cholesterol esterification inhibition and gemcitabine
synergistically suppress pancreatic ductal adenocarcinoma
proliferation. PLoS One. 13:e01933182018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fan J, Shan C, Kang HB, Elf S, Xie J,
Tucker M, Gu TL, Aguiar M, Lonning S, Chen H, et al: Tyr
phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3
to regulate the pyruvate dehydrogenase complex. Mol Cell.
53:534–548. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harris RA, Bowker-Kinley MM, Huang B and
Wu P: Regulation of the activity of the pyruvate dehydrogenase
complex. Advan Enzyme Regul. 42:249–259. 2002. View Article : Google Scholar
|
|
26
|
Zhao H, Jiang H, Li Z, Zhuang Y, Liu Y,
Zhou S, Xiao Y, Xie C, Zhou F and Zhou Y: 2-Methoxyestradiol
enhances radiosensitivity in radioresistant melanoma MDA-MB-435R
cells by regulating glycolysis via HIF-1α/PDK1 axis. Int J Oncol.
50:1531–1540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hitosugi T, Fan J, Chung TW, Lythgoe K,
Wang X, Xie J, Ge Q, Gu T, Polakiewicz RD, Roesel JL, et al:
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase
kinase 1 is important for cancer metabolism. Mol Cell. 44:864–877.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lin R, Elf S, Shan C, Kang HB, Ji Q, Zhou
L, Hitosugi T, Zhang L, Zhang S, Seo JH, et al: 6-Phosphogluconate
dehydrogenase links oxidative PPP, lipogenesis and tumour growth by
inhibiting LKB1-AMPK signalling. Nat Cell Biol. 17:1484–1496. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Buhman KF, Accad M and Farese RV:
Mammalian acyl-CoA:cholesterol acyltransferases. Biochim Biophys
Acta. 1529:142–154. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Behjati S, Tarpey PS, Haase K, Ye H, Young
MD, Alexandrov LB, Farndon SJ, Collord G, Wedge DC, Martincorena I,
et al: Recurrent mutation of IGF signalling genes and distinct
patterns of genomic rearrangement in osteosarcoma. Nat Commun.
8:159362017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Obr AE, Kumar S, Chang YJ, Bulatowicz JJ,
Barnes BJ, Birge RB, Lazzarino DA, Gallagher E, LeRoith D and Wood
TL: Insulin-like growth factor receptor signaling in breast tumor
epithelium protects cells from endoplasmic reticulum stress and
regulates the tumor microenvironment. Breast Cancer Res.
20:1382018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Cao HY, Guo XF, Zhu XF, Li SS and Zhen YS:
A ligand-based and enediyne-energized bispecific fusion protein
targeting epidermal growth factor receptor and insulin-like growth
factor-1 receptor shows potent antitumor efficacy against
esophageal cancer. Oncol Rep. 37:3329–3340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mano SS, Uto K and Ebara M:
Material-induced Senescence (MIS): Fluidity induces senescent type
cell death of lung cancer cells via insulin-like growth factor
binding protein 5. Theranostics. 7:4658–4670. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mochizuki S, Shimoda M, Abe H, Miyamae Y,
Kuramoto J, Aramaki-Hattori N, Ishii K, Ueno H, Miyakoshi A, Kojoh
K, et al: Selective inhibition of ADAM28 suppresses lung carcinoma
cell growth and metastasis. Mol Cancer Ther. 17:2427–2438. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Su X, Fang J, Xin X, Zhao X, Gaur
U, Wen Q, Xu J, Little PJ and Zheng W: Tanshinone IIA attenuates
insulin like growth factor 1-induced cell proliferation in PC12
cells through the PI3K/Akt and MEK/ERK pathways. Int J Mol Sci.
19(pii): E27192018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen X, Song Q, Xia L and Xu X: Synergy of
dendritic cell vaccines and avasimibe in treatment of head and neck
cancer in mice. Med Sci Monith. 23:4471–4476. 2017. View Article : Google Scholar
|
|
37
|
Bernard NJ: Cholesterol test for T cells.
Nat Rev Rheumatol. 15:1892019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li M, Yang Y, Wei J, Cun X, Lu Z, Qiu Y,
Zhang Z and He Q: Enhanced chemo-immunotherapy against melanoma by
inhibition of cholesterol esterification in CD8+ T
cells. Nanomedicine. 14:2541–2550. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kidani Y, Elsaesser H, Hock MB, Vergnes L,
Williams KJ, Argus JP, Marbois BN, Komisopoulou E, Wilson EB,
Osborne TF, et al: Sterol regulatory element-binding proteins are
essential for the metabolic programming of effector T cells and
adaptive immunity. Nat Immunol. 14:489–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Molnár E, Swamy M, Holzer M, Beck-García
K, Worch R, Thiele C, Guigas G, Boye K, Luescher IF, Schwille P, et
al: Cholesterol and sphingomyelin drive ligand-independent T-cell
antigen receptor nanoclustering. J Biol Chem. 287:42664–42674.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Zhao L, Li J, Liu Y, Kang L, Chen H, Jin
Y, Zhao F, Feng J, Fang C, Zhu B, et al: Cholesterol esterification
enzyme inhibition enhances antitumor effects of human chimeric
antigen receptors modified T cells. J Immunother. 41:45–52.
2018.PubMed/NCBI
|
|
42
|
Yang W, Bai Y, Xiong Y, Zhang J, Chen S,
Zheng X, Meng X, Li L, Wang J, Xu C, et al: Potentiating the
antitumour response of CD8(+) T cells by modulating cholesterol
metabolism. Nature. 531:651–655. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Wang H, Yang S, Wang Y, Jiang T, Li S and
Lv Z: Immunoenhancement effects of glycosaminoglycan from
Apostichopus japonicus: In vitro and in
cyclophosphamide-induced immunosuppressed mice studies. Mar Drugs.
15(pii): E3472017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhu G, Jiang Y, Yao Y, Wu N, Luo J, Hu M,
Tu Y and Xu M: Ovotransferrin ameliorates the dysbiosis of
immunomodulatory function and intestinal microbiota induced by
cyclophosphamide. Food Funct. 10:1109–1122. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Cheng D, Wan Z, Zhang X, Li J, Li H and
Wang C: Dietary chlorella vulgaris ameliorates altered
immunomodulatory functions in cyclophosphamide-induced
immunosuppressive mice. Nutrients. 9(pii): E7082017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chang TY, Li BL, Chang CC and Urano Y:
Acyl-coenzyme A: Cholesterol acyltransferases. Am J Physiol
Endocrinol Metab. 297:E1–E9. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pal P, Gandhi H, Giridhar R and Yadav MR:
ACAT inhibitors: The search for novel cholesterol lowering agents.
Mini Rev Med Chem. 13:1195–1219. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sistigu A, Viaud S, Chaput N, Bracci L,
Proietti E and Zitvogel L: Immunomodulatory effects of
cyclophosphamide and implementations for vaccine design. Semin
Immunopathol. 33:369–383. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Ganz PA, Romond EH, Cecchini RS, Rastogi
P, Geyer CE Jr, Swain SM, Jeong JH, Fehrenbacher L, Gross HM,
Brufsky AM, et al: Long-Term Follow-up of cardiac function and
quality of life for patients in NSABP protocol B-31/NRG oncology: A
randomized trial comparing the safety and efficacy of doxorubicin
and cyclophosphamide (AC) followed by paclitaxel with ac followed
by paclitaxel and trastuzumab in patients with node-positive breast
cancer with tumors overexpressing human epidermal growth factor
receptor 2. J Clin Oncol. 35:3942–3948. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Garderet L, Kuhnowski F, Berge B, Roussel
M, Escoffre-Barbe M, Lafon I, Facon T, Leleu X, Karlin L, Perrot A,
et al: Pomalidomide, cyclophosphamide, and dexamethasone for
relapsed multiple myeloma. Blood. 132:2555–2563. 2018. View Article : Google Scholar : PubMed/NCBI
|
